Company
Prelude Therapeutics Incorporated
Prelude Therapeutics Incorporated has 1 drug tracked on RxWires: 1 in Phase 1.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| PRT13722 | Phase 1 | Breast Cancer |
Latest
No recent events.
Follow Prelude Therapeutics Incorporated on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.